Keyphrases
Immunoreactivity
100%
Patients with Heart Failure
100%
Angiotensin-converting Enzyme Inhibition
100%
Plasma Brain Natriuretic Peptide
100%
Brain Natriuretic Peptide
45%
Human Brain
45%
Atrial Natriuretic Peptide
36%
Captopril
36%
Congestive Heart Failure
27%
Moderate to Severe
18%
Placebo
18%
Angiotensin II (Ang II)
18%
Blood Pressure
9%
Plasma Parameters
9%
Angiotensin-converting Enzyme Inhibitor (ACEi)
9%
Mean Arterial Pressure
9%
Male Patients
9%
Healthy Males
9%
Peripheral Plasma
9%
Semi-recumbent Position
9%
Oral Tablets
9%
Pharmacology, Toxicology and Pharmaceutical Science
Enzyme Inhibition
100%
Brain Natriuretic Peptide
100%
Dipeptidyl Carboxypeptidase
100%
Congestive Heart Failure
100%
Atrial Natriuretic Factor
66%
Captopril
66%
Placebo
33%
Angiotensin II
33%
Tablet
16%
Dipeptidyl Carboxypeptidase Inhibitor
16%